Schonfeld Strategic Advisors LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1665241 NEW YORK, NY

Position in FULC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$58,845

-$131,061 QoQ

Shares Held

16,078

-4.2% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#107

of 154 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. FULC ranks #122 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$58,845	16,078	-4.2%	Shares	Sole	2026-08-14
2025-12-31	$189,906	16,791	-95.4%	Shares	Sole	2026-02-17
2025-09-30	$3,369,987	366,303	+79.2%	Shares	Sole	2025-11-14
2025-06-30	$1,406,272	204,400	+600.7%	Shares	Sole	2025-08-14
2024-03-31	$275,355	29,169	-93.3%	Shares	Sole	2024-05-15
2023-12-31	$2,919,597	432,533	+305.8%	Shares	Sole	2024-02-14
2022-12-31	$776,048	106,600	+60.1%	Shares	Sole	2023-02-14
2022-09-30	$538,794	66,600	+117.6%	Shares	Sole	2022-11-14
2022-06-30	$149,940	30,600	-22.7%	Shares	Sole	2022-08-15
2022-03-31	$936,540	39,600	+11.5%	Shares	Sole	2022-05-16
2021-12-31	$627,995	35,500	-56.8%	Shares	Sole	2022-02-14
2021-09-30	$2,316,041	82,100	—	Shares	Sole	2021-11-16
No filing history on record for this holder in this stock.